TP53 and cancer: Patients with p53 mutant cancers often have poor prognoses in treatments; however, to date it remains unclear which particular p53 mutants cause this to be so, how significant the impacts are for each mutant, and in each case the exact mechanistic bases for the clinical observations with respect to chemotherapy resistance.